For common solid tumours, it is often impossible for a surgeon to remove the mass lesion with clear operative margins. Conventional external beam radiotherapy can be given to improve local tumour control, either before or after the surgery. The greater the effective dose of radiotherapy given the greater the improvement in the rate of local tumour control. This was illustrated by the Swedish Rectal Trial, in which combined preoperative external beam radiotherapy and surgery was compared with surgery alone (N Engi J Med 1997; 336: 980). The irradiation did not increase postoperative mortality; and after five years of follow-up the rate of local recurrence was 1 % in the group that received radiotherapy before surgery and 27% in the group treated with surgery alone (P<0.001). But external beam radiotherapy is limited in its effective dose by normal-tissue damage. The beam reaches the site of the tumour by passing through the uninvolved 'critical tissues' of the body to reach the 'tumour target volume', the intended site of treatment. The higher the effective dose to these tissues and the greater their volume, the greater is the risk of normal-tissue fibrosis and necrosis. Systems such as 'conformal radiotherapy' may reduce these risks by use of beam-shaping devices and three-dimensional physics planning computers to conform the high dose areas of the radiation beams over the tumour target volume while minimizing dose to the surrounding normal tissues. In prostate cancer, patients receiving conformal radiotherapy had a substantially lower rate of proctitis after treatment than those randomized to conventional treatment with the same dose, though tumour control and survival did not differ (Lancet 1999; 353: 267) . Conformal radiotherapy is being used in the Medical Research Council RTO 1 trial to test the safety and effectiveness of a 15.6% increase in radiation dose for early prostate cancer. In Intraoperative Irradiation, Leonard Gunderson and others review the intraoperative techniques which may deliver substantially greater effective doses of radiotherapy to the tumour target volume, with correspondingly greater potential for improving local tumour control. Intraoperative external beam radiotherapy permits large increases in the dose by physical removal of critical normal tissues out of the path of the high dose radiation. At operation, these normal tissues are moved aside, and a beam of radiotherapy is directed at the site of tumour. In the past, the anaesthetized patient had to be taken to the radiotherapy department for treatment a major disincentive to developing this treatment unless a hospital was prepared to fund a dedicated radiotherapy-equipped operating theatre. Now mobile radiotherapy machines such as the Mobetron or Novac-7 can be taken into conventional operating theatres. An example of this strategy is the Mayo Clinic programme for locally advanced rectal carcinoma (Int J Radiat Biol Phys 1997; 37: 601). Another method is brachytherapy, for which high-doserate machines are becoming available in most radiotherapy departments. They are portable units which use small radioactive metal sources in the form of metal beads that can be delivered by remote control to sites 2 metres away through flexible fine-bore cannulae. The rapid fall-off in radiation dose with distance from the source means that the surgeon must position the cannulae at the site of the tumour. This limits the dose to surrounding critical normal tissues, which can be protected further by shielding behind sterile lead sheets or discs. Treatment times may be as short as a few minutes, and structures as small as the lumen of a coronary artery may be treated. Multiple cannulae may be placed in parallel to treat large targets such as pelvic side walls involved by bowel cancer, as used at the Memorial Sloan Kettering Cancer Center for primary unresectable or locally recurrent rectal cancer (Int J Radiat Biol Phys 1998; 42: 325). The technical advances in the specialized radiotherapy machines now permit most cancer centres to consider an intraoperative radiotherapy programme.
This excellent and well referenced book would serve as an introduction and stimulus to many cancer treatment teams. It includes chapters on the physical and radiobiological science, descriptions of the techniques and machines, the requirements for treatment facilities, normal tissue toxicity, treatment outcomes by disease sites, and discussion of future possibilities.
